100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting Ziekteleer 2024 $10.39
Add to cart

Summary

Samenvatting Ziekteleer 2024

 1 view  0 purchase
  • Course
  • Institution

Samenvatting alle hoofdstukken van Ziekteleer (van de 4 proffen samen)

Preview 10 out of 96  pages

  • December 14, 2024
  • 96
  • 2024/2025
  • Summary
avatar-seller
1

Ziekteleer

Inhoud
Gastro-intestinale ziekteleer ......................................................................................................... 9
Slokdarm (oesophagus) .............................................................................................................. 9
Maag.................................................................................................................................................. 12
Ulcus ............................................................................................................................................. 12
Functionele darmstoornissen ...................................................................................................13
IBS .................................................................................................................................................13
Functionele dyspepsie = non-ulcer dyspepsie ............................................................... 14
Coeliakie ..........................................................................................................................................15
Inflammatoire darmziekte .........................................................................................................15
IBD .................................................................................................................................................15
Hemorroïden (aambeien) examen ........................................................................................... 17
Hepatische ziekteleer ..................................................................................................................... 18
Inleiding algemeen ...................................................................................................................... 18
Hepatitis.......................................................................................................................................... 18
Hepatitis B .................................................................................................................................. 18
Hepatitis C .................................................................................................................................. 20
Hepatitis D................................................................................................................................... 21
Alcoholische hepatitis ................................................................................................................. 21
Klinisch spectrum .................................................................................................................... 22
Symptomen (!!) ......................................................................................................................... 22
Prognose & therapie ............................................................................................................... 22
Toxische hepatitis ........................................................................................................................ 22
Medicamenteuze hepatitis = DILI ........................................................................................ 23
NAFLD en NASH........................................................................................................................... 23
NAFLD ......................................................................................................................................... 23
Metabool syndroom ................................................................................................................ 23
Ziekteprogressie in fatty liver disease..............................................................................24
Diagnose NAFLD ......................................................................................................................24
Pancreatitis ...................................................................................................................................24
Acute pancreatitis........................................................................................................................24
Medisch diagnostisch proces ....................................................................................................... 26
Anamnese + lichamelijk onderzoek ....................................................................................... 26
Aanvullende testen ..................................................................................................................... 26

,2

Medische besliskunde ................................................................................................................ 27
Scoresystemen............................................................................................................................. 27
Acromegalie ...................................................................................................................................... 27
Groeihormoon: productie .......................................................................................................... 27
Groeihormoon: acties ................................................................................................................. 27
Acromegalie: bepaling, oorzaak, tekenen ............................................................................ 27
Diagnose & behandeling ............................................................................................................ 28
Gynaecologie ..................................................................................................................................... 28
Polycysteus ovariumsyndroom (PCOS) ................................................................................ 28
Endometriose ................................................................................................................................ 29
Bepaling, symptomen, mechanisme .................................................................................. 29
Ectopische zwangerschap .................................................................................................... 29
Schildklier ...........................................................................................................................................31
Aandoeningen schildklier ...........................................................................................................31
Struma- goiter ...............................................................................................................................31
Schildklierfunctie ..........................................................................................................................31
Hyperthyreoïdie – thyreotoxicose ...........................................................................................31
Mola gravidarum ...................................................................................................................... 32
Schildklier scintigrafie ........................................................................................................... 32
Ziekte van Graves .................................................................................................................... 32
Hypothyreoïdie .............................................................................................................................. 32
Primaire hypothyreoïdie: oorzaken .................................................................................... 33
Behandeling ............................................................................................................................... 33
Atherosclerose – aorta aneurysma ........................................................................................... 33
Atherosclerose ............................................................................................................................. 33
Plotse hartdood ............................................................................................................................34
Acute ischemie .............................................................................................................................34
CVA = cerebrovasculair accident (beroerte ....................................................................34
Acuut myocard infarct ............................................................................................................ 35
Abdominale atherosclerose ................................................................................................. 35
Perifeer vaatlijden – occlusie .............................................................................................. 35
Perifeer vaatlijden – claudicatio ......................................................................................... 35
Lange-termijn behandeling ...................................................................................................... 35
Aorta-aneurysma ........................................................................................................................ 36
Aneurysma ................................................................................................................................. 36
Aorta-aneurysma .................................................................................................................... 36

,3

Cerebraal aneurysma ............................................................................................................. 36
Thoracaal aorta aneurysma ................................................................................................. 36
Abdominaal aorta aneurysma.............................................................................................. 36
Thoraco- Abdominaal aorta aneurysma ........................................................................... 37
Aorta aneurysma – risicofactoren ..................................................................................... 37
Aorta aneurysma – diagnose ............................................................................................... 37
Complicaties – dissectie ........................................................................................................ 37
Complicaties – ruptuur .......................................................................................................... 37
Aorta aneurysma – behandeling ......................................................................................... 37
Infectieziekten: pathofysiologie & algemene aspecten – sepsis & septische shock ..38
Definitie infectieziekte ................................................................................................................38
Routes van besmetting ..............................................................................................................38
(Micro)-organismen ....................................................................................................................38
Microbiële virulentie ...................................................................................................................38
Primair pathogene MO ........................................................................................................... 39
Potentieel pathogeen MO ...................................................................................................... 39
Opportunistisch pathogeen MO ........................................................................................... 39
Afweermechanismen van gastheer ....................................................................................... 39
Humorale afweer .................................................................................................................... 40
Cellulaire afweer: fagocyten ............................................................................................... 40
Cellulaire afweer: T-cellen .................................................................................................. 40
Epidemiologie van (infectie)ziekten ...................................................................................... 40
Endemisch vs epidemisch ..................................................................................................... 41
Epidemiologie............................................................................................................................ 41
Aanvullende diagnostiek ....................................................................................................... 41
Microbiologische diagnostiek............................................................................................... 41
Sepsis .............................................................................................................................................. 41
Oude definitie sepsis............................................................................................................... 41
Nieuwe definities .....................................................................................................................42
Epidemiologie sepsis ..............................................................................................................42
Etiologie ......................................................................................................................................42
Pathogenese..............................................................................................................................42
Sepsis: prognose .....................................................................................................................43
Sepsis: behandeling ................................................................................................................43
Sepsis zonder duidelijke orgaanlokalisatie .....................................................................43
Bijnierpathologie ............................................................................................................................. 44

,4

Anatomie ....................................................................................................................................... 44
Hypothalamus – hypofyse – bijnier ....................................................................................... 44
Renine-angiotensine-aldosteron .......................................................................................... 44
Bijnieraandoeningen: bijnierschors ...................................................................................... 44
Overproductie glucocorticoïden: syndroom van Cushing........................................... 44
Onderproductie gluco-en mineralocorticoïden: ziekte van Addison .......................45
Overproductie mineralocorticoïden: syndroom van Conn ..........................................45
Effecten glucocorticoïden.......................................................................................................... 46
Bijnieraandoeningen: bijniermerg .......................................................................................... 46
Overproductie catecholamines: feochromocytoom ...................................................... 46
Bacteriële infectieziekten.............................................................................................................. 46
Lyme borreliose ........................................................................................................................... 46
Verloop ziekte ........................................................................................................................... 46
Diagnose ..................................................................................................................................... 47
Preventie .................................................................................................................................... 47
Behandeling ............................................................................................................................... 47
Oorzaken therapie falen ....................................................................................................... 48
Syfilis .............................................................................................................................................. 48
Primaire syfilis ........................................................................................................................ 48
Secundaire syfilis ................................................................................................................... 48
Latente syfilis........................................................................................................................... 48
Tertiaire syfilis ......................................................................................................................... 48
Diagnose syfilis ....................................................................................................................... 48
Behandeling syfilis .................................................................................................................. 49
Kattenkrabziekte .......................................................................................................................... 49
Kattenkrabziekte: kliniek ....................................................................................................... 49
Kattenkrabziekte: lymfadenopathie ................................................................................... 49
Kattenkrabziekte: zeldzame gevallen ...............................................................................50
Kattenkrabziekte: diagnose ..................................................................................................50
Kattenkrabziekte: behandeling ............................................................................................50
Brucellose ......................................................................................................................................50
Brucellose: kliniek ...................................................................................................................50
Brucellose: diagnose ..............................................................................................................50
Brucellose: behandeling ........................................................................................................50
Infectieuze endocarditis ............................................................................................................50
Oorzakelijke kiemen ................................................................................................................51

,5

Vegetatie ......................................................................................................................................51
Gevolgen ......................................................................................................................................51
Kliniek: aspecifieke klachten .................................................................................................51
Verwikkelingen ..........................................................................................................................51
Diagnose ......................................................................................................................................51
Behandeling ............................................................................................................................... 52
Acute bacteriële meningitis ...................................................................................................... 52
Risicofactoren ........................................................................................................................... 52
Symptomen & tekens.............................................................................................................. 52
Verwikkelingen ......................................................................................................................... 53
Diagnose ..................................................................................................................................... 53
Profylaxe bij meningokokken meningitis ......................................................................... 53
Preventie meningitis ............................................................................................................... 53
Hyperlipidemie.................................................................................................................................. 53
Vetzuren .........................................................................................................................................54
Lipoproteïne ..................................................................................................................................54
Functies ..........................................................................................................................................54
Classificatie plasma lipoproteïnen .........................................................................................55
Klinisch belang hyperlipidemie ...............................................................................................55
Classificatie hyperlipidemie volgens pathogenese ...........................................................55
Polygenetische hypercholesterolemie: 1/6 ......................................................................55
Familiale hypercholesterolemie heterozygoot 1/500 ................................................... 56
Familiale gecombineerde hyperlipidemie ........................................................................ 56
Familiale dysbetalipoproteinemie ...................................................................................... 56
Familiale LPL of apo CII deficiëntie .................................................................................... 56
Classificatie hyperlipidemie volgens primaire vs secundaire ....................................... 56
Behandeling hyperlipidemie ..................................................................................................... 56
Voeding ....................................................................................................................................... 57
Fysieke activiteit & rookstop ................................................................................................ 57
Medicatie .................................................................................................................................... 57
Parasitaire infecties........................................................................................................................58
Malaria ............................................................................................................................................58
Immuniteit ..................................................................................................................................58
Incubatie ..................................................................................................................................... 59
Symptomen ................................................................................................................................ 59
Verwikkelingen ......................................................................................................................... 59

,6

Diagnose ..................................................................................................................................... 59
Behandeling ............................................................................................................................... 59
Preventie naar lokale bevolking ......................................................................................... 59
Preventie bij reizigers ............................................................................................................ 60
Toxoplasmose ............................................................................................................................... 60
Diagnose – behandeling – preventie .................................................................................. 61
Schistosomiasis ............................................................................................................................ 61
Katayama .................................................................................................................................... 62
Diagnose ..................................................................................................................................... 62
Behandeling ............................................................................................................................... 62
Preventie .................................................................................................................................... 62
Echinococcose .............................................................................................................................. 62
Symptomen ................................................................................................................................ 63
Diagnose – behandeling ........................................................................................................ 63
Strongyloidiasis............................................................................................................................ 63
Diagnose ..................................................................................................................................... 64
Behandeling ............................................................................................................................... 64
Filariase .......................................................................................................................................... 64
Wuchereria bancrofti .............................................................................................................. 64
Loa Loa ....................................................................................................................................... 64
Onchocerca volvulus .............................................................................................................. 64
Longziekten ....................................................................................................................................... 65
Sarcoïdose ..................................................................................................................................... 65
Sarcoïdose: epidemiologie .................................................................................................... 65
Sarcoïdose: etiologie .............................................................................................................. 65
Sarcoïdose: pathogenese ...................................................................................................... 65
Sarcoïdose: kliniek .................................................................................................................. 66
Sarcoïdose: orgaanaantasting ............................................................................................. 66
Sarcoïdose: diagnose.............................................................................................................. 67
Sarcoïdose: behandeling ....................................................................................................... 67
Tuberculose ................................................................................................................................... 68
Epidemiologie tuberculose ................................................................................................... 68
Tuberculose in België ............................................................................................................. 68
Geslacht, leeftijd, nationaliteit ............................................................................................. 68
Tuberculose pathofysiologie ................................................................................................ 68
Tuberculose klinische manifestaties ................................................................................. 69

,7

Tuberculose: long .................................................................................................................... 69
Tuberculose: pleura ................................................................................................................ 69
Tuberculose: miliair ................................................................................................................ 69
Tuberculose: klier .................................................................................................................... 70
Tuberculose: skelet ................................................................................................................. 70
Tuberculose: CZS ..................................................................................................................... 70
Tuberculose: abdominaal ...................................................................................................... 70
Tuberculose: genito-urinair .................................................................................................. 70
Tuberculose: pericard............................................................................................................. 70
Tuberculose: diagnose ........................................................................................................... 70
Tuberculose: behandeling ...................................................................................................... 71
Resistente tuberculose ........................................................................................................... 71
Tuberculose: preventie............................................................................................................ 71
Pneumonie ...................................................................................................................................... 71
Pneumonie: pathofysiologie ................................................................................................. 72
CAP: Streptococcus pneumoniae........................................................................................ 72
CAP: Mycoplasma pneumoniae ........................................................................................... 72
CAP: klinische manifestaties ................................................................................................ 72
CAP: diagnose ........................................................................................................................... 72
CAP: behandeling ..................................................................................................................... 73
CAP: preventie .......................................................................................................................... 73
Nosocomiale pneumonie: definities ................................................................................... 73
HAP/VAP kliniek ....................................................................................................................... 74
HAP/VAP diagnose .................................................................................................................. 74
HAP/VAP behandeling ............................................................................................................ 74
Hartritmestoornissen ..................................................................................................................... 75
Pathofysiologie ............................................................................................................................. 75
Elektrische geleiding hart ..................................................................................................... 75
AP hart ........................................................................................................................................ 75
ECG ............................................................................................................................................... 75
Diagnose – symptoom ritmecorrelatie ............................................................................. 76
Aritmogenese............................................................................................................................ 76
Bradycardie ................................................................................................................................... 77
Sinus bradycardie .................................................................................................................... 77
Sick sinus syndroom (SSS) .................................................................................................. 77
Atrioventriculair blok (AV-blok).......................................................................................... 77

,8

Tachycardie .................................................................................................................................... 78
Geïsoleerde ectopie ................................................................................................................ 78
Bigeminie – trigeminie ........................................................................................................... 79
Runs van ectopie...................................................................................................................... 79
Ectopie......................................................................................................................................... 79
Tachycardie ................................................................................................................................ 79
Supraventriculaire tachycardie ........................................................................................... 79
Ventriculaire ritmestoornissen ............................................................................................... 81
Ventrikel tachycardie .............................................................................................................. 81
Bloedings-en stollingsstoornissen ............................................................................................ 82
Hemostase ..................................................................................................................................... 82
Verhoogde tromboseneiging ....................................................................................................85
Veneuze trombo-embolie (VTE) ..........................................................................................85
Verhoogde bloedingsneiging .................................................................................................... 89
Infectieziekten veroorzaakt door virussen .............................................................................. 90
Influenza ......................................................................................................................................... 90
Pandemische griep................................................................................................................... 91
Vogelgriep .................................................................................................................................. 92
Seizoensgriep ........................................................................................................................... 92
Overdracht Influenza .............................................................................................................. 92
Symptomen influenza bij volwassenen ............................................................................ 92
Influenza complicaties ........................................................................................................... 92
Influenza diagnose .................................................................................................................. 92
Influenza preventie.................................................................................................................. 93
Antivirale therapie ................................................................................................................... 93
Herpes virus infecties ................................................................................................................ 93
Epstein-Barr virus................................................................................................................... 93
CMV .............................................................................................................................................. 93
Herpes simplex ........................................................................................................................ 94
Varicella zoster ........................................................................................................................ 94
Hantavirus...................................................................................................................................... 95
HIV en AIDS: aanvullingen ..................................................................................................... 95
HIV teststrategie: doel ............................................................................................................ 95
HIV infectie gevolgen .............................................................................................................. 95
Combinatietherapie ................................................................................................................. 95

,9




Gastro-intestinale ziekteleer
- Slokdarm: achalasie, slokdarmspasmen, GERD & maligne tumoren
- Maag: ulcuslijden, gastritis, maligne tumoren
- Functionele darmstoornissen: IBS, functionele dyspepsie
- Coeliakie
- Inflammatoire darmziekten: ziekte van Crohn, colitis ulcerosa
- Diverticulitis = ontsteking van kleine uitstulpingen in dikke darm (divertikels)
- Hemorroïden




Slokdarm (oesophagus)
- Functie: aboraal transport van voedselbolus & speeksel + voorkomen van
reflux van maaginhoud
- Via: peristaltiek (primaire, secundaire), sfinctermechanismen (cricopharyngeus,
GES) & neuronale controle (inhibitie & excitatie)
- Peristaltiek: spieren contraheren waardoor de passageweg smaller wordt & de
voedselbolus naar beneden wordt getrokken => bij voedselbolus relaxeren
spieren waardoor passageweg breder wordt zodat voedselbolus kan passeren




- Symptomen bij slokdarmpathologie: dysfagie (moeilijk slikken), odynofagie (pijn
bij slikken), regurgitatie (terug naar boven komen van onverteerd voedsel),
pyrosis (reflux), aspiratie(maaginhoud komt via mond terug naar binnen =>
longen), gewichtsverlies, bloedverlies, globusgevoel, halitose (slechte
ademgeur) examen
- Onderzoek bij slokdarmpathologie: examen
o Oesophagoscopie: met endoscoop kijken of mucosa ontstoken is van
slokdarm

, 10




o Röntgenonderzoek: met contrastvloeistof => kijken of contrastvloeistof bijft
hangen (tumoren)
o Manometrisch onderzoek: verschillende kanalen in slokdarm om peristal te
meten, volgt normaal een bepaald patroon => indien afwijkingen wijst dit op
een pathologie (als contracties allemaal tegelijk gebeuren)
o Ambulante pH meting: buisje met meetpunten voor pH te meten gedurende
24u, indien reflux = lagere pH in slokdarm (want maagzuur komt in slokdarm)
▪ Gouden standaard voor diagnose GERD
▪ Kwantificatie tijd dat mucosa blootgesteld wordt aan maagzuur
▪ Meet vermogen van slokdarm om refluxzuur te clearen
o Impedantie meting: meting elektrische weerstand, indien er een voedselbolus
aanwezig is, zijn er veel ionen aanwezig dus lage impedantie




- Slokdarmpathologie:

o Motorische stoornissen:
▪ Achalasie (examen): een motiliteitsstoornis van de slokdarm,
progressieve ziekte gekenmerkt door dysfagie voor vast & vloeibaar
voedsel
• Prevalentie: 7-32/100 000
• Meestal tussen 40 & 60 jaar
• Geen peristaltiek in slokdarm = simultane contracties =>
slokdarm is heel breed
• Lage gastro-oesofageale sfincter (GES) dilateert niet, hoge GES
tonus
• Progressieve obstructie slokdarm => geen passage naar darm
• Oorzaak: denervatie van inhibitorische neuronen tgv
progressieve degeneratie ganglioncellen thv. myenterische
plexus in slokdarmwand => inhibitie valt weg
• Primair: idiopathisch => vermoedelijk auto-immuunziekte +
genetische predispositie

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller noavdn. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.39. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

52510 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$10.39
  • (0)
Add to cart
Added